Cargando…
Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells
Serving as the metabolic hub of the human body, the liver is a vital organ that performs a variety of important physiological functions. Although known for its regenerative potential, it remains vulnerable to a variety of diseases. Despite decades of research, liver disease remains a leading cause o...
Autores principales: | Blaszkiewicz, Josef, Duncan, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030659/ https://www.ncbi.nlm.nih.gov/pubmed/35456379 http://dx.doi.org/10.3390/genes13040573 |
Ejemplares similares
-
iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
por: Corbett, James L., et al.
Publicado: (2019) -
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
por: Liu, Jui-Tung, et al.
Publicado: (2023) -
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
por: Kiamehr, Mostafa, et al.
Publicado: (2017) -
iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery
por: Gurevich, Igor, et al.
Publicado: (2020) -
Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021)